My watch list
my.bionity.com  
Login  
NEWS
Current news

TTP Group opens Pharmaplan branch in Munich

17-Sep-2021 TTP Group continues to grow. In September, a new Pharmaplan branch was opened in Munich. With now 26 locations in Europe and India, TTP Group thus continues to focus on customer proximity. With the new office in Boschetsrieder Straße, Pharmaplan GmbH covers the region of southern Germany as ... more

Sartorius to open new Application & Service Hub in Shanghai

Significantly extended capabilities in biological drug discovery, process development, testing and validation to meeting growing local customer demand

17-Sep-2021 The life science group Sartorius officially opened its new, significantly expanded Application and Service Hub in Zhangjiang Science City in Shanghai, China. Equipped with the latest innovative instrumentation and offering cutting-edge professional expertise, this Hub covering over 3,000 sq ... more

Machine learning assisted structure analysis reveals SARS-CoV-2 virus tactics

The proteins of Covid-19

17-Sep-2021 The proteins of SARS-CoV-2 play key roles in how the virus manages to evade immune defense and replicate itself in patients’ cells. An international research team – with significant contribution from the Technical University of Munich (TUM) – has now compiled the most detailed view of the v ... more

Can cocoa consumption help us age better?

Particularly dark chocolate is regularly touted for its health benefits

17-Sep-2021 Whether consuming cocoa, known to be packed with powerful antioxidants that protect our cells from damage, helps us age better, is a question scientists want to definitively answer. They are looking for answers in the blood of 600 individuals age 60 and older who participated in the largest ... more

Protein from the liver may cause Alzheimer’s disease in the brain

Peripherally produced amyloid causes neurodegeneration

17-Sep-2021 Amyloid protein made in the liver can cause neurodegeneration in the brain, according to a new study in the open-access journal PLOS Biology, by John Mamo of Curtin University in Bentley, Australia, and colleagues. Since the protein is thought to be a key contributor to development of Alzhe ... more

“Sustainable tires through dandelions – innovations from biology, technology and agriculture” joint research project shows that a new, alternative raw material supply is possible

Team of Continental, Fraunhofer IME and the University of Münster Nominated for Federal President's Award

16-Sep-2021 Dr. Carla Recker (Continental), Prof. Dr. Dirk Prüfer (University of Münster) and Dr. Christian Schulze Gronover (Fraunhofer Institute for Molecular Biology and Applied Ecology IME) have been nominated for the Federal President's Award for Technology and Innovation 2021 (“Deutscher Zukunfts ... more

Novel seed treatment technology is reducing the need for synthetic fertilizers

Andes raises USD 15 million in Series A funding co-led by Leaps by Bayer and Cavallo Ventures

16-Sep-2021 Leaps by Bayer, the impact investment arm of Bayer AG, announced that it has co-led a USD 15 million Series A investment round in agriculture and biotechnology innovator, Andes, with Cavallo Ventures. Other new investors Builders VC, Germin8, Accelr8 and Wilson Sonsini participated, alongsi ... more

Bridging antibodies plus enhancer can destroy breast cancer cells

16-Sep-2021 Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have developed antibodies that have two antigen-binding sites and can couple cancer cells with effector cells of the immune system. In laboratory tests, these bridging antibodies, together with an enh ... more

Can You Lose Weight?

Ask Your Microbiome

16-Sep-2021 The strongest associations with weight loss success or failure – independent of BMI – are found in the genetic capacity of the gut microbiome. These new findings open the door to diagnostic tests that can identify people likely to lose weight with healthy lifestyle changes and those who mig ... more

CureVac Streamlines European Network for mRNA Product Manufacturing

Contracts with manufacturing partners WACKER and Celonic terminated

15-Sep-2021 CureVac N.V. announced its strategic decision to adjust the long-term footprint of the external European manufacturing network for its mRNA product pipeline. The decision was made in response to the reduced short-term peak demand for vaccines following the first wave of the pandemic vaccina ... more

All news

Machine learning assisted structure analysis reveals SARS-CoV-2 virus tactics

The proteins of Covid-19

17-Sep-2021 The proteins of SARS-CoV-2 play key roles in how the virus manages to evade immune defense and replicate itself in patients’ cells. An international research team – with significant contribution from the Technical University of Munich (TUM) – has now compiled the most detailed view of the v ... more

Listening in on laundry germs as they grow

First metatranscriptome study for washed laundry

08-Sep-2021 Germans wash more than 5 kg of laundry per week. What many people don‘t realize is that even freshly washed laundry still contains significant amounts of microorganisms such as bacteria and fungi. A group of researchers led by Prof. Dr. Markus Egert at Furtwangen University (HFU) has been i ... more

Cancer cells on the wrong path

How adaptations can make cancer treatment more difficult

01-Sep-2021 Each tumor consists of multiple cell types, all of which have distinct characteristics. In addition to determining the course of the disease, these differences between individual cancer cells control the effectiveness of targeted therapies. A team of researchers from Charité – Universitätsm ... more

Taking aim at skin bacteria

Enzyme treatment of skin samples improves microbiome analysis

13-Aug-2021 Healthy skin has a bacterial shield to protect against germs: the microbiome. This complex assembly of microorganisms was previously believed to be difficult to decipher. A team of researchers has now succeeded in using the enzyme benzonase to identify the living bacteria in skin swabs thro ... more

Illuminating tissue formation

09-Aug-2021 Researchers at ETH Zurich have developed a molecule that fluoresces where new tissue is forming in the body. Alongside helping to detect tumours, the molecule could play a significant role in research of wound healing disorders. Collagen is the most abundant protein in the human body. It ma ... more

Novel method for fast 3D microscopy

03-Aug-2021 Researchers at the ImmunoSensation2 Cluster of Excellence at the University of Bonn, the University Hospital and the research center caesar have develop a method that allows using multi-focal images to reconstruct the movement of fast biological processes in 3D. In the past, many discoveri ... more

TSUBAME supercomputer predicts cell-membrane permeability of cyclic peptides

30-Jul-2021 Scientists at Tokyo Institute of Technology have developed a computational method based on large-scale molecular dynamics simulations to predict the cell-membrane permeability of cyclic peptides using a supercomputer. Their protocol has exhibited promising accuracy and may become a useful t ... more

Toxicity testing on the placenta and embryo

Detection substances that are harmful to the embryo at an early stage of drug development

23-Jul-2021 Researchers at ETH Zurich have developed a cell culture test to detect substances that are directly or indirectly harmful to embryos. Based on an existing test used for developing new drugs and chemicals, the augmented version is designed to help reduce the number of animal experiments. Dru ... more

Human environmental genome recovered in the absence of skeletal remains

Innovative approach permits the identification of DNA in samples of environmental material

14-Jul-2021 Ancient sediments from caves have already proven to preserve DNA for thousands of years. The amount of recovered sequences from environmental sediments, however, is generally low, which difficults the analyses to be performed with these sequences. A study led by Ron Pinhasi and Pere Gelaber ... more

MaxDIA – taking proteomics to the next level

Highly sensitive and accurate data analysis: New software improves data-independent acquisition proteomics

12-Jul-2021 Proteomics produces enormous amounts of data, which can be very complex to analyze and interpret. The free software platform MaxQuant has proven to be invaluable for data analysis of shotgun proteomics over the past decade. Now, Jürgen Cox, group leader at the Max Planck Institute of Bioche ... more

All news on bioanalytics

Sartorius to open new Application & Service Hub in Shanghai

Significantly extended capabilities in biological drug discovery, process development, testing and validation to meeting growing local customer demand

17-Sep-2021 The life science group Sartorius officially opened its new, significantly expanded Application and Service Hub in Zhangjiang Science City in Shanghai, China. Equipped with the latest innovative instrumentation and offering cutting-edge professional expertise, this Hub covering over 3,000 sq ... more

“Sustainable tires through dandelions – innovations from biology, technology and agriculture” joint research project shows that a new, alternative raw material supply is possible

Team of Continental, Fraunhofer IME and the University of Münster Nominated for Federal President's Award

16-Sep-2021 Dr. Carla Recker (Continental), Prof. Dr. Dirk Prüfer (University of Münster) and Dr. Christian Schulze Gronover (Fraunhofer Institute for Molecular Biology and Applied Ecology IME) have been nominated for the Federal President's Award for Technology and Innovation 2021 (“Deutscher Zukunfts ... more

Novel seed treatment technology is reducing the need for synthetic fertilizers

Andes raises USD 15 million in Series A funding co-led by Leaps by Bayer and Cavallo Ventures

16-Sep-2021 Leaps by Bayer, the impact investment arm of Bayer AG, announced that it has co-led a USD 15 million Series A investment round in agriculture and biotechnology innovator, Andes, with Cavallo Ventures. Other new investors Builders VC, Germin8, Accelr8 and Wilson Sonsini participated, alongsi ... more

CureVac Streamlines European Network for mRNA Product Manufacturing

Contracts with manufacturing partners WACKER and Celonic terminated

15-Sep-2021 CureVac N.V. announced its strategic decision to adjust the long-term footprint of the external European manufacturing network for its mRNA product pipeline. The decision was made in response to the reduced short-term peak demand for vaccines following the first wave of the pandemic vaccina ... more

Engineered E. coli could make carbohydrates, renewable fuel, from CO2

"The key is for a microbe to use formate as its sole carbon source"

15-Sep-2021 Researchers from Newcastle University, UK have engineered Escherichia coli bacteria to capture carbon dioxide (CO2) using hydrogen gas (H2) to convert it into formic acid. The research, published in Applied and Environmental  Microbiology raises the possibility of converting atmospheric CO2 ... more

Step by step to the end product through enzyme catalysis

Enzymes from microorganisms can produce valuable chemical substances. In a cascade, they can do that even if they need different environmental conditions

02-Sep-2021 The production of the sugar trehalose, which is used as a functional food and an additive in pharmaceutical products or in cosmetics, is a team effort for enzymes: One takes care of the construction of an energy-rich intermediate product (UDP-glucose), from which the second then makes treha ... more

Galapagos announces planned retirement of CEO

The Supervisory Board has initiated an external search for replacement

31-Aug-2021 Galapagos NV announces the planned retirement of CEO Onno van de Stolpe. Onno van de Stolpe co-founded Galapagos in 1999 and built and led the company as CEO from its early R&D days through to the commercial launch of Jyseleca® (filgotinib) in Europe. Onno will retire and make way for a new ... more

Using yeast to create alternative petrochemical processes

Integrating cellular engineering with cell-free biosynthesis could lead to efficient ways to power the earth

30-Aug-2021 As climate change continues to do more damage to our planet, scientists are working to find more efficient and cleaner ways to power the earth. One appealing alternative to common petrochemical processes that generate significant greenhouse gases and other waste products could come from bio ... more

Cardior Raises EUR 64 Million to Develop RNA Therapeutics Against Cardiac Disease

Start-up pursues a unique approach for the treatment

27-Aug-2021 Cardior Pharmaceuticals has closed a Series B financing round totalling EUR 64 million (USD 76 million). The round was led by Inkef Capital, supported by fellow new investors Fund+, Sunstone, Hadean Ventures and Coparion with participation from existing investors including LSP, BioMed Partn ... more

Understanding enzyme evolution paves the way for green chemistry

How evolution makes designer enzymes more powerful, paving the way to tailor-made catalysts

26-Aug-2021 Researchers at the University of Bristol have shown how laboratory evolution can give rise to highly efficient enzymes for new-to-nature reactions, opening the door for novel and more environmentally friendly ways to make drugs and other chemicals. Scientists have previously designed protei ... more

All news on biotechnology

Can You Lose Weight?

Ask Your Microbiome

16-Sep-2021 The strongest associations with weight loss success or failure – independent of BMI – are found in the genetic capacity of the gut microbiome. These new findings open the door to diagnostic tests that can identify people likely to lose weight with healthy lifestyle changes and those who mig ... more

World First: Smallest biosupercapacitor provides energy for biomedical applications

Smaller than a speck of dust: Biocompatible energy storage device for sensor applications in blood vessels

25-Aug-2021 The miniaturization of microelectronic sensor technology, microelectronic robots or intravascular implants is progressing rapidly. However, it also poses major challenges for research. One of the biggest is the development of tiny but efficient energy storage devices that enable the operati ... more

Canine Diag’noses’

Dogs can detect SARS-CoV-2 infected humans on all tested body fluids with high accuracy

25-Aug-2021 A research team led by the University of Veterinary Medicine Hannover (TiHo), in cooperation with the Bundeswehr, the Hannover Medical School and the University Medical-Center Hamburg-Eppendorf, published a new study and a review article in the journal BMC Infectious Diseases on detection d ... more

An implantable AI system

Using AI for early detection and treatment of illnesses

23-Aug-2021 TU Dresden scientists at the Chair of Optoelectronics have succeeded for the first time in developing a bio-compatible implantable AI platform that classifies in real time healthy and pathological patterns in biological signals such as heartbeats. It detects pathological changes even withou ... more

Blood-based micro-RNAs indicate the risk of colorectal cancer

Promising new method to determine a person's individual risk of disease more accurately

19-Aug-2021 The risk of colorectal cancer can be predicted more accurately by determining seven blood-based micro-RNAs (miRNAs) than by using traditional methods - and can be done so many years before a diagnosis is made. In a current study, researchers from the German Cancer Research Center and the Na ... more

Cancer screening from home?

Detection with independently taken samples can work

12-Aug-2021 A large proportion of women who develop cervical cancer in high-income countries such as Germany do not regularly attend screening. This is particularly alarming, as cancer screenings have become much less frequent since the onset of the corona pandemic. A study by Hannover Medical School a ... more

Tecan successfully completes the acquisition of Paramit

05-Aug-2021 The Tecan Group  announced that it has successfully completed the acquisition of US-based Paramit Corporation and its affiliates (“Paramit”) for a total purchase consideration of USD 1.0 billion (CHF 920 million). On June 23, 2021, Tecan entered into a definitive agreement to acquire Parami ... more

Cancerous tumours: how likely are they to metastasise?

23-Jul-2021 A very aggressive type of cancer has provided a team of researchers with an answer to the question of which tumour cells are at risk of spreading. Cancer treatment is sometimes complicated by the heterogeneity of the cells that form the tumour mass. The problem is how to identify the few ce ... more

XPhyto signs transformative acquisition agreement with 3a-diagnostics

Enter hi-tech biosensor market and expand its diagnostic product portfolio

22-Jul-2021 XPhyto Therapeutics Corp. announced that it has signed a definitive agreement for the acquisition of 3a-diagnostics GmbH, Frickenhausen, Germany. Pursuant to the definitive agreement, XPhyto will acquire all of the outstanding shares of 3a for EUR 400,000, to be paid immediately, and EUR 3. ... more

Corona test with cotton swab

New study examines alternative screening options

20-Jul-2021 To diagnose an infection with the coronavirus, usually a throat swab is taken and genetic viral material detected by using a highly sensitive PCR. To date, more than 65 million of these tests have been performed in Germany alone. Due to the massive increase in testing worldwide and simultan ... more

All news on diagnostics

Tecan successfully completes the acquisition of Paramit

05-Aug-2021 The Tecan Group  announced that it has successfully completed the acquisition of US-based Paramit Corporation and its affiliates (“Paramit”) for a total purchase consideration of USD 1.0 billion (CHF 920 million). On June 23, 2021, Tecan entered into a definitive agreement to acquire Parami ... more

Sartorius continues on its fast growth trajectory

Significant double-digit increases in sales and earnings

22-Jul-2021 Sartorius has continued on its fast growth trajectory, closing the first half of 2021 with significant double-digit increases in both sales revenue and order intake. “In the first six months of the year, we have seen unabated high demand for innovative technologies used in the development a ... more

Simplified method for calibrating optical tweezers

Broadband measurement of viscoelasticity with reduced measurement time

20-Jul-2021 Measurements of biomechanical properties inside living cells require minimally invasive methods. Optical tweezers are particularly attractive as a tool. It uses the momentum of light to trap and manipulate micro- or nanoscale particles. A team of researchers led by Prof. Dr. Cornelia Denz f ... more

OLS OMNI Life Science and Namocell sign distribution agreement

Single cell sorting and dispensing instruments now available in Germany and Austria

13-Jul-2021 OLS OMNI Life Science announced a distribution agreement with Namocell Inc., a provider of high-performance single cell sorting and dispensing platforms. As of now on OLS OMNI Life Science offers an expanded cell research portfolio focused next to single cell sorting and dispensing on cell ... more

Remote-controlled labs - Lab of the future is liberating scientists from the limitations of their location

California-based startup Strateos closes $56 Million Series B financing

10-Jun-2021 Strateos, Inc., a pioneer in the development of remote access laboratories and lab control software for life science research, announced the closing of its $56.1 million Series B financing led by DCVC and Lux Capital with participation from new investors including Eli Lilly and Company, All ... more

An AI Robot for Pipetting

Researchers from the University of Freiburg have received an EXIST grant for their goodBot startup

31-May-2021 Pipettes are important tools for scientists when transporting liquids in medical, pharmaceutical, biology, and chemistry laboratories. Using pipettes precisely is especially important when repeating experiments. The University of Freiburg researchers Julius Wiener, Tobias Zundel, and Oliver ... more

PerkinElmer to Acquire Nexcelom Bioscience

14-May-2021 PerkinElmer, Inc. announced it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash. The transaction is expected to close during the second quarter of 2021.Nexcelom is a global provider of automated cell counting instruments, image cytometry workstations, as ... more

Eppendorf achieves record revenue and best result in the company’s history in 2020

Revenue rises by 20.3% to €967.2 million in 2020

06-May-2021 In fiscal year 2020, Eppendorf AG succeeded in posting record revenue of €967 million (prior year: €804 million) – a significant year-on-year increase of 20.3% (prior year: 10.2%). EBIT likewise saw a sharp rise of €73.5 million to €217.7 million (prior year: €144.2 million), representing a ... more

New dimension for efficient laboratory work

Laboratory SaaS provider Labforward ramps up Series B financing to >€8.5 million in second closing

06-May-2021 With the successful completion of a second closing, Labforward adds >€3m to the Series B from January, bringing the total funds raised to >€8.5m. The majority of the new investment comes from the Fielmann Family Office, majority owner of the leading German family business of the same name t ... more

Lab supplies out of the 3D printer

LAUDA invests in Better Basics start-up

18-Mar-2021 LAUDA will cooperate with Better Basics Laborbedarf GmbH (BBL). The Dresden-based company, founded in 2019, develops, manufactures and sells smart basic equipment for laboratories that simplifies the organization of laboratory workstations and supports laboratory employees in their daily wo ... more

All news on laboratory equipment / laboratory supplies

TTP Group opens Pharmaplan branch in Munich

17-Sep-2021 TTP Group continues to grow. In September, a new Pharmaplan branch was opened in Munich. With now 26 locations in Europe and India, TTP Group thus continues to focus on customer proximity. With the new office in Boschetsrieder Straße, Pharmaplan GmbH covers the region of southern Germany as ... more

Sartorius to open new Application & Service Hub in Shanghai

Significantly extended capabilities in biological drug discovery, process development, testing and validation to meeting growing local customer demand

17-Sep-2021 The life science group Sartorius officially opened its new, significantly expanded Application and Service Hub in Zhangjiang Science City in Shanghai, China. Equipped with the latest innovative instrumentation and offering cutting-edge professional expertise, this Hub covering over 3,000 sq ... more

CureVac Streamlines European Network for mRNA Product Manufacturing

Contracts with manufacturing partners WACKER and Celonic terminated

15-Sep-2021 CureVac N.V. announced its strategic decision to adjust the long-term footprint of the external European manufacturing network for its mRNA product pipeline. The decision was made in response to the reduced short-term peak demand for vaccines following the first wave of the pandemic vaccina ... more

Exploiting deep learning to develop sustainable COVID-19 inhibitors

Collaboration Eisbach Bio GmbH & Technische Universität Kaiserslautern

10-Sep-2021 Eisbach Bio GmbH and the team of Prof. Dr.-Ing. Naim Bajcinca from the Technische Universität Kaiserlautern (TUK) announce a collaboration where they will use deep learning to track and trace arising mutations in the genome of SARS-CoV-2 and develop sustainable small molecule inhibitors tha ... more

Sanofi to acquire Kadmon

09-Sep-2021 Sanofi has entered into a definitive merger agreement with Kadmon Holdings, Inc. a biopharmaceutical company that discovers, develops, and markets transformative therapies for disease areas of significant unmet medical needs. The acquisition supports Sanofi’s strategy to continue to grow it ... more

Galapagos announces planned retirement of CEO

The Supervisory Board has initiated an external search for replacement

31-Aug-2021 Galapagos NV announces the planned retirement of CEO Onno van de Stolpe. Onno van de Stolpe co-founded Galapagos in 1999 and built and led the company as CEO from its early R&D days through to the commercial launch of Jyseleca® (filgotinib) in Europe. Onno will retire and make way for a new ... more

Cardior Raises EUR 64 Million to Develop RNA Therapeutics Against Cardiac Disease

Start-up pursues a unique approach for the treatment

27-Aug-2021 Cardior Pharmaceuticals has closed a Series B financing round totalling EUR 64 million (USD 76 million). The round was led by Inkef Capital, supported by fellow new investors Fund+, Sunstone, Hadean Ventures and Coparion with participation from existing investors including LSP, BioMed Partn ... more

FDA Approves First COVID-19 Vaccine

24-Aug-2021 The U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccin ... more

How much does it really cost to develop a new drug?

18-Aug-2021 Along with direct investments, the high risk of failure and the considerable time to market all determine the costs of drug development. Yet how much does it really cost to develop a new drug? Published estimates arrive at very different results. Scientists from the German Cancer Research C ... more

CureVac’s Second-Generation Vaccine Candidate Demonstrates Improved Immune Response and Protection

The optimized mRNA backbone has the potential for a multivalent or combination approach to address multiple emerging variants in one vaccine

17-Aug-2021 CureVac N.V. and GSK announced the publication of preclinical data investigating immune responses as well as the protective efficacy of CureVac’s first-generation vaccine candidate, CVnCoV, and second-generation vaccine candidate, CV2CoV, against SARS-CoV-2 challenge in non-human primates. ... more

All news on pharma

Machine learning assisted structure analysis reveals SARS-CoV-2 virus tactics

The proteins of Covid-19

17-Sep-2021 The proteins of SARS-CoV-2 play key roles in how the virus manages to evade immune defense and replicate itself in patients’ cells. An international research team – with significant contribution from the Technical University of Munich (TUM) – has now compiled the most detailed view of the v ... more

Can cocoa consumption help us age better?

Particularly dark chocolate is regularly touted for its health benefits

17-Sep-2021 Whether consuming cocoa, known to be packed with powerful antioxidants that protect our cells from damage, helps us age better, is a question scientists want to definitively answer. They are looking for answers in the blood of 600 individuals age 60 and older who participated in the largest ... more

Protein from the liver may cause Alzheimer’s disease in the brain

Peripherally produced amyloid causes neurodegeneration

17-Sep-2021 Amyloid protein made in the liver can cause neurodegeneration in the brain, according to a new study in the open-access journal PLOS Biology, by John Mamo of Curtin University in Bentley, Australia, and colleagues. Since the protein is thought to be a key contributor to development of Alzhe ... more

Bridging antibodies plus enhancer can destroy breast cancer cells

16-Sep-2021 Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have developed antibodies that have two antigen-binding sites and can couple cancer cells with effector cells of the immune system. In laboratory tests, these bridging antibodies, together with an enh ... more

Can You Lose Weight?

Ask Your Microbiome

16-Sep-2021 The strongest associations with weight loss success or failure – independent of BMI – are found in the genetic capacity of the gut microbiome. These new findings open the door to diagnostic tests that can identify people likely to lose weight with healthy lifestyle changes and those who mig ... more

COVID-19: What is driving the escalating hyperinflammation

Study published in Nature suggests novel treatment option

15-Sep-2021 The severity of COVID-19 is not determined solely by the SARS-CoV-2 virus itself; rather, it is the primary result of a dysregulated immune response. A team of researchers from Charité – Universitätsmedizin Berlin, the Max-Delbrück-Center for Molecular Medicine (MDC), Johannes Kepler Univer ... more

Fountain of youth for ageing stem cells in bone marrow

Epigenetic changes in old age increase risk of osteoporosis and bone fractures

15-Sep-2021 As we age, our bones become thinner, we suffer fractures more often, and diseases like osteoporosis can occur. One of the culprits is ageing stem cells in the bone marrow, which are no longer as effective at replenishing the bones. Researchers from the Max Planck Institute for Biology of Ag ... more

Persistent dysfunction in natural killer cells has been implicated in severe COVID-19 progressions

14-Sep-2021 Based on previous studies of the COVID-19 pandemic, it is known that a specific form of white immune cells, natural killer (NK) cells, make an important contribution to the early antiviral immune response against SARS-CoV-2. An international team led by the University of Bonn has now found ... more

Insights into the cellular and molecular changes in male infertility

14-Sep-2021 “You can’t see the wood for the trees” is a phrase which we certainly don’t associate immediately with the medical examination and analysis of testicles. But in a certain way it applies here, too: testicles consist of many different types of cells, and up to now this complex quality prevent ... more

Signs of dementia are written in the blood

33 metabolic compounds linked to dementia could be key to new methods of diagnosis and treatment

14-Sep-2021 Scientists in Japan have identified metabolic compounds within the blood that are associated with dementia. The study revealed that the levels of 33 metabolites differed in patients with dementia, compared to elderly people with no existing health conditions. Their findings, published in PN ... more

All news on healthcare
News by department
  • Products

    CureVac Streamlines European Network for mRNA Product Manufacturing

    Contracts with manufacturing partners WACKER and Celonic terminated

    15-Sep-2021 CureVac N.V. announced its strategic decision to adjust the long-term footprint of the external European manufacturing network for its mRNA product pipeline. The decision was made in response to the reduced short-term peak demand for vaccines following the first wave of the pandemic vaccina ... more

    Exploiting deep learning to develop sustainable COVID-19 inhibitors

    Collaboration Eisbach Bio GmbH & Technische Universität Kaiserslautern

    10-Sep-2021 Eisbach Bio GmbH and the team of Prof. Dr.-Ing. Naim Bajcinca from the Technische Universität Kaiserlautern (TUK) announce a collaboration where they will use deep learning to track and trace arising mutations in the genome of SARS-CoV-2 and develop sustainable small molecule inhibitors tha ... more

    FDA Approves First COVID-19 Vaccine

    24-Aug-2021 The U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccin ... more

  • Business

    TTP Group opens Pharmaplan branch in Munich

    17-Sep-2021 TTP Group continues to grow. In September, a new Pharmaplan branch was opened in Munich. With now 26 locations in Europe and India, TTP Group thus continues to focus on customer proximity. With the new office in Boschetsrieder Straße, Pharmaplan GmbH covers the region of southern Germany as ... more

    Sartorius to open new Application & Service Hub in Shanghai

    Significantly extended capabilities in biological drug discovery, process development, testing and validation to meeting growing local customer demand

    17-Sep-2021 The life science group Sartorius officially opened its new, significantly expanded Application and Service Hub in Zhangjiang Science City in Shanghai, China. Equipped with the latest innovative instrumentation and offering cutting-edge professional expertise, this Hub covering over 3,000 sq ... more

    Sanofi to acquire Kadmon

    09-Sep-2021 Sanofi has entered into a definitive merger agreement with Kadmon Holdings, Inc. a biopharmaceutical company that discovers, develops, and markets transformative therapies for disease areas of significant unmet medical needs. The acquisition supports Sanofi’s strategy to continue to grow it ... more

  • Price Development

    Are the high prices of cancer drugs justified?

    Does the cost correspond to the particular drug’s effectiveness in combating the disease?

    05-May-2020 Do high prices of some cancer medicines have a higher benefit than those drugs with lower prices? An international UZH study has concluded that, in general, there is no correlation between costs of a cancer drugs and their clinical benefit. The researchers are therefore calling for the clin ... more

    Drug costs vary by more than 600% in study of 10 high-income countries

    13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

  • Research

    Machine learning assisted structure analysis reveals SARS-CoV-2 virus tactics

    The proteins of Covid-19

    17-Sep-2021 The proteins of SARS-CoV-2 play key roles in how the virus manages to evade immune defense and replicate itself in patients’ cells. An international research team – with significant contribution from the Technical University of Munich (TUM) – has now compiled the most detailed view of the v ... more

    Can cocoa consumption help us age better?

    Particularly dark chocolate is regularly touted for its health benefits

    17-Sep-2021 Whether consuming cocoa, known to be packed with powerful antioxidants that protect our cells from damage, helps us age better, is a question scientists want to definitively answer. They are looking for answers in the blood of 600 individuals age 60 and older who participated in the largest ... more

    Protein from the liver may cause Alzheimer’s disease in the brain

    Peripherally produced amyloid causes neurodegeneration

    17-Sep-2021 Amyloid protein made in the liver can cause neurodegeneration in the brain, according to a new study in the open-access journal PLOS Biology, by John Mamo of Curtin University in Bentley, Australia, and colleagues. Since the protein is thought to be a key contributor to development of Alzhe ... more

  • People

    Galapagos announces planned retirement of CEO

    The Supervisory Board has initiated an external search for replacement

    31-Aug-2021 Galapagos NV announces the planned retirement of CEO Onno van de Stolpe. Onno van de Stolpe co-founded Galapagos in 1999 and built and led the company as CEO from its early R&D days through to the commercial launch of Jyseleca® (filgotinib) in Europe. Onno will retire and make way for a new ... more

    Eppendorf Award for Young European Investigators 2021 goes to Tanmay Bharat

    „His work has far-reaching general implication and also opens the door for the development of new antibiotics that are urgently needed“

    28-Jun-2021 In 2021, Eppendorf AG, the Hamburg life sciences company, is presenting its research prize for the 26th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn announced Dr. Tanmay Bharat, Sir William Dunn School of Pathology, University of Oxford, United Kingdom as the wi ... more

    Former Merck CEO appointed Chair of the AiCuris Supervisory Board

    26-May-2021 AiCuris Anti-infective Cures AG announced that the Supervisory Board appointed Dr. Stefan Oschmann as chairman. He succeeds Helmut Jeggle, Chief Executive Officer of Salvia GmbH, who stepped down as planned from his role as Interim-Chairman of the initial Supervisory Board of AiCuris AG. He ... more

  • Finances

    Novel seed treatment technology is reducing the need for synthetic fertilizers

    Andes raises USD 15 million in Series A funding co-led by Leaps by Bayer and Cavallo Ventures

    16-Sep-2021 Leaps by Bayer, the impact investment arm of Bayer AG, announced that it has co-led a USD 15 million Series A investment round in agriculture and biotechnology innovator, Andes, with Cavallo Ventures. Other new investors Builders VC, Germin8, Accelr8 and Wilson Sonsini participated, alongsi ... more

    Cardior Raises EUR 64 Million to Develop RNA Therapeutics Against Cardiac Disease

    Start-up pursues a unique approach for the treatment

    27-Aug-2021 Cardior Pharmaceuticals has closed a Series B financing round totalling EUR 64 million (USD 76 million). The round was led by Inkef Capital, supported by fellow new investors Fund+, Sunstone, Hadean Ventures and Coparion with participation from existing investors including LSP, BioMed Partn ... more

    Ascenion’s portfolio company T-knife receives $110 million for the development of innovative T-cell therapies in cancer

    Initiation of the IMAGE1NE Phase 1/2 clinical study of TK-8001, a TCR-T cell therapy for MAGE-A1 positive solid tumors, in Q4 2021

    05-Aug-2021 T-knife Therapeutics, Inc., a next-generation T-cell receptor company developing innovative therapeutics for solid tumor patients, today announced the successful completion of a $110 million Series B financing. The financing was led by Fidelity Management & Research Company, LLC., with part ... more

  • Cooperation

    Exploiting deep learning to develop sustainable COVID-19 inhibitors

    Collaboration Eisbach Bio GmbH & Technische Universität Kaiserslautern

    10-Sep-2021 Eisbach Bio GmbH and the team of Prof. Dr.-Ing. Naim Bajcinca from the Technische Universität Kaiserlautern (TUK) announce a collaboration where they will use deep learning to track and trace arising mutations in the genome of SARS-CoV-2 and develop sustainable small molecule inhibitors tha ... more

    AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity

    Novel small molecule drug candidates will target GPR75 to potentially address obesity and related co-morbidities

    29-Jul-2021 AstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialise small molecule compounds directed against the GPR75 target with the potential to treat obesity and related co-morbidities. The companies will evenly split research and development costs and sh ... more

    OLS OMNI Life Science and Namocell sign distribution agreement

    Single cell sorting and dispensing instruments now available in Germany and Austria

    13-Jul-2021 OLS OMNI Life Science announced a distribution agreement with Namocell Inc., a provider of high-performance single cell sorting and dispensing platforms. As of now on OLS OMNI Life Science offers an expanded cell research portfolio focused next to single cell sorting and dispensing on cell ... more

  • Technology

    World's first toxicology testing strategy without animal testing adopted by OECD

    Success for long-standing collaboration between BASF and Givaudan to develop and validate alternative methods

    30-Jun-2021 The world’s first toxicology testing strategy without animal testing has been approved by the OECD (Organisation for Economic Co-operation and Development). The testing strategy consists of three so-called alternative methods. They can be used to predict whether a substance causes allergic ... more

    Evonik makes follow-on investment into In Ovo to support launch of gender-testing machine for eggs

    Biotechnology start-up reaches commercialization stage for its technology

    06-Apr-2021 Evonik has made a follow-up investment in the biotechnology start-up In Ovo through its venture capital unit. The investment comes as the young company reaches the commercialization stage for its technology and is bringing its gender-testing machine for eggs to the market. Together with co- ... more

    High-tech start-ups benefit from Twitter hype

    Study shows correlation between Twitter sentiment and the valuation of start-ups by venture capitalists

    18-Feb-2021 The short message service Twitter has played a prominent role in US politics in recent weeks and months and attracted a lot of attention. Even in business, Twitter users' tweets are being closely followed and used as a basis for decision-making. A new study shows that venture capitalists ca ... more

  • Laws

    Japan and Singapore Grant CRISPR Patents to Merck

    27-Nov-2019 Merck announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application for the use of paired CRISPR nickases, bringing Merck’s number of patents to 22 worldwide. “Paired nickases represent a significant step in incre ... more

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

    05-Mar-2019 Merck announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells. The patent provides an important and more specific solution for scientists who need accurate methods when developing treatments for diffi ... more

  • Market

    M&A in chemicals and life sciences slowed down by global lockdowns

    Race for COVID-19 vaccine

    13-Jul-2020 In the first half of this year, the transaction volume of mergers and acquisitions in the chemical and life sciences industries has decreased dramatically. The volume of deals announced in the first six months is only $84 billion. Compared to the previous year (389 billion dollars), this is ... more

    Many of the deadliest cancers receive the least amount of research funding

    'Embarrassing' or stigmatized cancers like lung and liver are underfunded

    23-Jul-2019 Many of the deadliest or most common cancers get the least amount of nonprofit research funding, according to a new Northwestern Medicine study that examined the distribution of nonprofit research funding in 2015 across cancer types. Colon, endometrial, liver and bile duct, cervical, ovaria ... more

    Gene Editing Tools Gain an Uptick in Sales With Emphasis on Rare Genetic Disorder Management

    22-Jul-2019 According to latest research by FMI, the global gene editing tools market is estimated to have accounted for more than US$ 258 Mn in terms of value in 2018. The report on the gene editing tools market further projects that the gene editing tools market is likely to grow at a CAGR of over 18 ... more

  • Politics

    What the Biden-Harris administration means for chemistry

    The new administration has inherited a global pandemic and worsening climate change, among other science-related issues

    10-Feb-2021 The inauguration of Joe Biden and Kamala Harris marks a new era for science policy in the U.S. and beyond. The new administration has inherited a global pandemic and worsening climate change, among other science-related issues. A cover story in Chemical & Engineering News (C&EN), the weekly ... more

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    ECETOC Task Force provides new insights

    Toxicity testing of microparticles and poorly soluble liquids in the water environment

    15-Jan-2019 A Task Force set up by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) has provided new insights into scientific testing for the impact of undissolved particles in the aquatic environment. ECETOC launched the Task Force in response to increasing concerns among the ... more

  • Manufacturing

    CureVac Streamlines European Network for mRNA Product Manufacturing

    Contracts with manufacturing partners WACKER and Celonic terminated

    15-Sep-2021 CureVac N.V. announced its strategic decision to adjust the long-term footprint of the external European manufacturing network for its mRNA product pipeline. The decision was made in response to the reduced short-term peak demand for vaccines following the first wave of the pandemic vaccina ... more

    Rentschler Biopharma breaks ground at new U.S. production site in greater Boston

    Multi-product facility to focus on commercial production of complex molecules for U.S.-based clients

    16-Aug-2021 Rentschler Biopharma announced that the company has broken ground at its new production site, adjacent to its existing site in Milford, MA in the greater Boston area. The new Rentschler Biopharma Manufacturing Center US (RBMC US) will add 22,000 square feet of manufacturing cleanroom space ... more

    Heraeus expands capacity for platinum-based active pharmaceutical ingredients to treat cancer

    12-Aug-2021 Heraeus has significantly built up its manufacturing capacity for active pharmaceutical ingredients to fight cancer. The company announced that its new production line for platinum-based pharmaceutical ingredients located at its headquarters in Hanau is now running at full speed, and custom ... more

  • Career

    Eppendorf with worldwide setting program

    Around 250 vacancies at all locations by the end of 2019

    26-Apr-2019 The Eppendorf Group is creating around 250 new jobs worldwide this year. A large proportion of the new jobs will be created in Hamburg at the headquarters of the globally active life sciences company and is an important component of Eppendorf's growth strategy. "Eppendorf is growing strongl ... more

    Lower pension, shorter life

    12-Apr-2019 Income and social status have an increasing effect on life expectancy in Germany. On average, men with very low retirement pay die five years earlier than those who are much better off. Poverty shortens life. According to a study by researchers at the Max Planck Institute for Demographic Re ... more

    KNAUER among the top one percent of employers in Germany

    28-Feb-2019 In the study "Leading Employers Germany 2019", the Berlin-based manufacturer of high-tech laboratory measuring instruments KNAUER was ranked as one of the best employers for the second time. This makes KNAUER one of the companies with the best ratings in an independent meta-study conducted ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE